<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772092/" ref="ordinalpos=811&amp;ncbi_uid=5336264&amp;link_uid=PMC3772092" image-link="/pmc/articles/PMC3772092/figure/pone-0075489-g007/" class="imagepopup">Figure 7. TGF-β <span class="highlight" style="background-color:">signaling</span> in EMT program in thyroid cells..  From: Cadherin 6 Is a New RUNX2 Target in TGF-? Signalling <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Schematic representation of the TGF-β dependent EMT program in thyroid cells. Malignant transformation of thyroid cells is accompanied by a constitutive activation of the TGF-β signaling pathway. TGF-β cascade controls the expression of a number of transcription factors (EMT-TF) including RUNX2 that alter the gene expression profile of the cells to activate the EMT program.</div></div>